Literature DB >> 28246433

Should pulse pressure influence prescribing?

Anthony M Dart1.   

Abstract

Keywords:  atherosclerosis; blood pressure; cardiovascular disease

Year:  2017        PMID： 28246433      PMCID： PMC5313243          DOI： 10.18773/austprescr.2017.006

Source DB:  PubMed          Journal:  Aust Prescr        ISSN： 0312-8008


× No keyword cloud information.
  13 in total

Review 1.  Pulse pressure--a review of mechanisms and clinical relevance.

Authors:  A M Dart; B A Kingwell
Journal:  J Am Coll Cardiol       Date:  2001-03-15       Impact factor: 24.094

2.  Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.

Authors:  D A Kass; E P Shapiro; M Kawaguchi; A R Capriotti; A Scuteri; R C deGroof; E G Lakatta
Journal:  Circulation       Date:  2001-09-25       Impact factor: 29.690

3.  The systolic blood pressure versus pulse pressure controversy.

Authors:  W B White
Journal:  Am J Cardiol       Date:  2001-06-01       Impact factor: 2.778

Review 4.  Mechanisms, pathophysiology, and therapy of arterial stiffness.

Authors:  Susan J Zieman; Vojtech Melenovsky; David A Kass
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-02-24       Impact factor: 8.311

5.  Diastolic blood pressure and mortality in the elderly with cardiovascular disease.

Authors:  Athanase D Protogerou; Michel E Safar; Pierre Iaria; Hélène Safar; Katia Le Dudal; Jan Filipovsky; Olivier Henry; Pierre Ducimetière; Jacques Blacher
Journal:  Hypertension       Date:  2007-05-21       Impact factor: 10.190

6.  Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study.

Authors:  S S Franklin; M G Larson; S A Khan; N D Wong; E P Leip; W B Kannel; D Levy
Journal:  Circulation       Date:  2001-03-06       Impact factor: 29.690

7.  Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?

Authors:  P Owens; E O'Brien
Journal:  Heart       Date:  1999-10       Impact factor: 5.994

8.  A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

Authors:  Carl J Pepine; Eileen M Handberg; Rhonda M Cooper-DeHoff; Ronald G Marks; Peter Kowey; Franz H Messerli; Giuseppe Mancia; José L Cangiano; David Garcia-Barreto; Matyas Keltai; Serap Erdine; Heather A Bristol; H Robert Kolb; George L Bakris; Jerome D Cohen; William W Parmley
Journal:  JAMA       Date:  2003-12-03       Impact factor: 56.272

9.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

10.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321
View more
  3 in total

Review 1.  A unified mapping framework of multifaceted pharmacodynamic responses to hypertension interventions.

Authors:  Qian Wang; Jingwen Gan; Kun Wei; Scott A Berceli; Claudia Gragnoli; Rongling Wu
Journal:  Drug Discov Today       Date:  2019-01-25       Impact factor: 7.851

2.  Pulse Pressure and Diabetic Eye Disease.

Authors:  Anthony M Dart
Journal:  J Am Heart Assoc       Date:  2019-04-16       Impact factor: 5.501

3.  Pulse pressure during the initial resuscitative period in patients with septic shock treated with a protocol-driven resuscitation bundle therapy.

Authors:  Sang-Hun Lee; Youn-Jung Kim; Gi Na Yu; Jae Cheon Jeon; Won Young Kim
Journal:  Korean J Intern Med       Date:  2020-08-20       Impact factor: 2.884
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.